FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for Celexa (citalopram) under NDA 020822.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• CELEXA (citalopram)

Snippet

SUPPL AP for CELEXA (CITALOPRAM)